Viscient Biosciences
Viscient Biosciences is a biotechnology company focused on utilizing 3D tissue technology to revolutionize drug development and disease modeling. They develop advanced human tissue models, such as liver models that mimic fatty liver disease, to replace outdated animal testing methods. The company's innovative approach aims to improve the accuracy and efficiency of drug discovery and disease research.
Industries
Nr. of Employees
small (1-50)
Products
Preclinical-stage drug candidate
Therapeutic candidate discovered and advanced to preclinical development using 3D human tissue models; preparation underway for Phase 1 clinical testing.
In-licensed clinical-stage drug candidate
Externally licensed therapeutic acquired for clinical development and planned for Phase 2 studies.
Preclinical-stage drug candidate
Therapeutic candidate discovered and advanced to preclinical development using 3D human tissue models; preparation underway for Phase 1 clinical testing.
In-licensed clinical-stage drug candidate
Externally licensed therapeutic acquired for clinical development and planned for Phase 2 studies.
Services
Development of three-dimensional human tissue constructs for research and preclinical testing of disease mechanisms and therapeutics.
Characterization of in vitro disease phenotypes using microscopy and gene expression profiling to validate model fidelity.
Use of tissue-engineered models to discover, evaluate, and advance therapeutic candidates toward clinical development.
Development of three-dimensional human tissue constructs for research and preclinical testing of disease mechanisms and therapeutics.
Characterization of in vitro disease phenotypes using microscopy and gene expression profiling to validate model fidelity.
Use of tissue-engineered models to discover, evaluate, and advance therapeutic candidates toward clinical development.
Expertise Areas
- 3D tissue modeling
- In vitro liver disease modeling (MASH/NASH)
- Preclinical drug discovery and candidate advancement
- Translational research for clinical entry
Key Technologies
- 3D human tissue models
- In vitro disease modeling
- Histology / microscopy
- Gene expression profiling
News & Updates
A news article about Viscient's work with 3D human liver models that produce accurate MASH (formerly NASH) phenotypes.
Development of a Liver Model with Disease Characteristics
Viscient's liver model was declared to contain all the characteristics of fatty liver disease by Dr. David Brenner, showing known disease patterns by microscopy and gene expression, as published in The American Journal of Pathology.
A news article about Viscient's work with 3D human liver models that produce accurate MASH (formerly NASH) phenotypes.
Development of a Liver Model with Disease Characteristics
Viscient's liver model was declared to contain all the characteristics of fatty liver disease by Dr. David Brenner, showing known disease patterns by microscopy and gene expression, as published in The American Journal of Pathology.